Inivata today announced it has launched its InVisionFirst Lung liquid biopsy in the U.S. through a commercial partnership with NeoGenomics. The device is a ctDNA next-generation sequencing liquid biopsy assay testing 37 genes that are relevant to the care of advanced non-small-cell lung cancer. The results are delivered within seven days and the test is […]
